Triple-negative breast cancer (TNBC) is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and the epidermal growth factor receptor 2 (HER2)1. This evidence concerns the gene PGR and triple-negative breast carcinoma.